Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-24-006081
Filing Date
2024-12-26
Accepted
2024-12-26 10:54:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13731
  Complete submission text file 0001085146-24-006081.txt   15690
Mailing Address ONE VANDERBILT AVENUE NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE NEW YORK NY 10017 212-827-6971
TD SECURITIES (USA) LLC (Filed by) CIK: 0000803012 (see all company filings)

EIN.: 581495511 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SCHEDULE 13G

Mailing Address 437 MADISON AVENUE 27TH FLOOR NEW YORK NY 10022
Business Address 437 MADISON AVENUE 27TH FLOOR NEW YORK NY 10022 6469785180
Denali Capital Acquisition Corp. (Subject) CIK: 0001913577 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93795 | Film No.: 241578615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)